💥 Gate广场活动: #FST创作大赛# 💥
在 Gate广场 发布 CandyDrop 第71期:CandyDrop x FreeStyle Classic Token (FST) 相关原创内容,即有机会瓜分 3,000 FST 奖励!
📅 活动时间:2025年8月27日 – 9月2日
📌 参与方式:
发布原创内容,主题需与 FST 或 CandyDrop 活动相关
内容不少于 80 字
帖子添加话题: #FST创作大赛#
附上 CandyDrop 参与截图
🏆 奖励设置:
一等奖(1名):1,000 FST
二等奖(3名):500 FST/人
三等奖(5名):200 FST/人
📄 注意事项:
内容必须原创,禁止抄袭或刷量
获奖者需完成 Gate 广场身份认证
活动最终解释权归 Gate 所有
活动详情链接: https://www.gate.com/announcements/article/46757
staked INJ ETF proposal
Key Points:* The U.S. SEC evaluates Canary Capital’s proposed Staked INJ ETF.
Canary Capital’s Staked INJ ETF: A Regulatory Milestone
Canary Capital, led by Steven McClurg, submitted a proposal for a Staked INJ ETF via Cboe’s platform, aiming to integrate Injective Protocol and staking rewards within an ETF structure. While this represents a milestone, official statements from Injective Labs are pending.
If approved, the ETF would offer investors access to Injective Protocol without technical hurdles, potentially boosting its ecosystem. This innovation follows the SEC’s recent clarifications on staking activities.
Market analysts anticipate heightened interest, although institutional sentiment varies. Investors and developers are closely monitoring the SEC’s position, which may shape future regulatory frameworks for crypto ETFs.
Injective Protocol: Expert Views and Market Data
Did you know? Canary Capital’s application is part of broader efforts to offer a diversified range of ETFs, including those involving major Layer-1 networks.
According to CoinMarketCap, the current market cap for Injective (INJ) stands at $1.29 billion, with a price of $12.91. Despite a recent decline in trading volume and price, INJ gained 21.03% over the past two months, reflecting interest amidst evolving market conditions.
Steven McClurg, Founder, Canary Capital, noted, “The ETF will allow investors to benefit from both price appreciation and staking yields — without the technical risks of direct on-chain participation.”
| | | --- | | DISCLAIMER: The information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing. |